Jade Biosciences (JBIO) Depreciation and Depletion (2021 - 2026)
Jade Biosciences posted quarterly Depreciation and Depletion of $9000.0 for Q1 2026, up 125.0% year-on-year from $4000.0 in Q1 2025, and little changed on a QoQ basis from $9000.0 in Q4 2025.
Jade Biosciences (JBIO) has 6 years of Depreciation and Depletion data on file, last reported at $9000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 125.0% year-over-year to $9000.0; the trailing twelve-month figure through Mar 2026 stood at $31000.0 (down 87.98% YoY), and the FY2025 full-year result was $26000.0, down 90.78% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $9000.0, roughly flat from $9000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $218000.0 in Q3 2024 and bottomed at $1000.0 in Q2 2025.
- The 5-year median for Depreciation and Depletion is $20000.0 (2022), against an average of $28294.1.
- The widest annual swing landed in 2024, when Depreciation and Depletion surged 772.0%; it then tumbled 96.43% in 2025.
- A 5-year view of Depreciation and Depletion shows it stood at $20000.0 in 2022, then surged by 40.0% to $28000.0 in 2023, then plunged by 71.43% to $8000.0 in 2024, then rose by 12.5% to $9000.0 in 2025, then changed by 0.0% to $9000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $9000.0 (Q1 2026), $9000.0 (Q4 2025), and $12000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |